 BOSTON, May 26, 2022 GLOBE NEWSWIRE -- Cue Biopharma, Inc. Nasdaq: CUE, a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the patients body, announced today it will give a poster presentation at the American Society of Clinical Oncology ASCO Annual Meeting to be held in-person June 37 at the McCormick Place Convention Center in Chicago, Illinois and virtually. 